Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

First phase I data presented for HM-15136

June 30, 2020

Japanese approval of Rybelsus for type 2 diabetes

June 29, 2020

FDA approves Mycapssa for long-term maintenance treatment in patients with acromegaly

June 29, 2020

First-in-human data presented for YG-1699

June 29, 2020

First patient dosed in phase I study of IMT-002

June 26, 2020

Interim data from phase II study of once-weekly setmelanotide formulation

June 26, 2020

IND clearance for phase II study of HST-5040 for methylmalonic acidemia and propionic acidemia

June 26, 2020

Phase III study of Ultomiris SC in PNH meets primary endpoint

June 25, 2020

Phase II data support progression of arimoclomol into pivotal-stage development in Gaucher disease

June 25, 2020

Chinese researchers divulge S1P receptor 1 agonists

June 25, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...